Suppr超能文献

查巴迪疟原虫抗原Pch105、恶性疟原虫抗原Pf155和红细胞带3共享交叉反应表位。

Plasmodium chabaudi antigen Pch105, Plasmodium falciparum antigen Pf155, and erythrocyte band 3 share cross-reactive epitopes.

作者信息

Holmquist G, Udomsangpetch R, Berzins K, Wigzell H, Perlmann P

机构信息

Department of Immunology, University of Stockholm, Sweden.

出版信息

Infect Immun. 1988 Jun;56(6):1545-50. doi: 10.1128/iai.56.6.1545-1550.1988.

Abstract

By immunoblotting with a number of monoclonal antibodies raised in human and murine malaria systems, we have been able to establish the presence of cross-reactive epitopes on the Plasmodium falciparum vaccine candidate antigen Pf155/RESA and its proposed Plasmodium chabaudi analog Pch105. These findings were confirmed when the same antibodies were tested in an immunofluorescence assay. By using short synthetic peptides corresponding to repeated sequences in the C terminus of the Pf155 and enzyme-linked immunosorbent assays, the cross-reacting epitope was found to be localized to this repeat segment. Furthermore, a monoclonal antibody to murine erythrocyte band 3 which also cross-reacted with human band 3 bound to both Pch105 and Pf155 as well as to the synthetic peptides, suggesting that these proteins share a related epitope. The cross-reactions reflect the existence of sequence homologies of band 3 with these plasmodial proteins. This molecular similarity may be used by the parasite to disturb the rigidity of the erythrocyte membrane, thereby facilitating its entrance into the cell.

摘要

通过用在人类和鼠类疟疾系统中产生的多种单克隆抗体进行免疫印迹,我们得以确定恶性疟原虫疫苗候选抗原Pf155/RESA及其拟似的查巴迪疟原虫类似物Pch105上存在交叉反应性表位。当在免疫荧光测定中检测相同抗体时,这些发现得到了证实。通过使用与Pf155 C末端重复序列相对应的短合成肽和酶联免疫吸附测定,发现交叉反应性表位定位于该重复片段。此外,一种与人类带3也发生交叉反应的抗鼠红细胞带3单克隆抗体与Pch105和Pf155以及合成肽都结合,这表明这些蛋白质共享一个相关表位。这些交叉反应反映了带3与这些疟原虫蛋白质存在序列同源性。寄生虫可能利用这种分子相似性来扰乱红细胞膜的刚性,从而便于其进入细胞。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d49f/259434/c0cf03046e45/iai00078-0148-a.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验